학술논문
A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer
Document Type
Article
Author
Veeraraghavan, J.; De Angelis, C.; Mao, R.; Wang, T.; Herrera, S.; Pavlick, A.C.; Contreras, A.; Nuciforo, P.; Mayer, I.A.; Forero, A.; Nanda, R.; Goetz, M.P.; Chang, J.C.; Wolff, A.C.; Krop, I.E.; Fuqua, S.A.W.; Prat, A.; Hilsenbeck, S.G.; Weigelt, B.; Reis-Filho, J.S.; Gutierrez, C.; Osborne, C.K.; Rimawi, M.F.; Schiff, R.
Source
In Annals of Oncology June 2019 30(6):927-933
Subject
Language
ISSN
0923-7534